Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766475 · ClinicalTrials.gov registry record · NA

In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression

A NA study of Postpartum Depression, sponsored by University of Denver.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
1
Study location

NCT05766475 is a NA study of Postpartum Depression that is actively recruiting participants, run by University of Denver. The registered enrollment target is 900 participants, above the 511-participant average among 38 other Postpartum Depression trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766475, a NA study of Postpartum Depression, is actively recruiting participants, sponsored by University of Denver.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test whether an established preventive intervention (group interpersonal therapy) delivered virtually shows the same benefits for preventing postpartum depression as it does when delivered in person.

Conditions Studied

Interventions

  • BEHAVIORAL ROSE Program: In Person
  • BEHAVIORAL ROSE Program: Virtual

Study Locations (1)

Colorado

  • Denver Health Medical Center - Denver

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2023-03-13
Est. Completion 2027-06
Phase NA

Sponsor

University of Denver

13 total trials

What the Registry Record Tells You About NCT05766475

The ClinicalTrials.gov registry entry for NCT05766475 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 511-participant average among 38 other Postpartum Depression trials with a reported enrollment target (76% higher). The listed sponsor is University of Denver, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which ROSE Program: In Person is the first listed.

NCT05766475 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT05766475 about?

NCT05766475 is a clinical study titled "In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression". The goal of this clinical trial is to test whether an established preventive intervention (group interpersonal therapy) delivered virtually shows the same benefits for preventing postpartum depression as it does when delivered in person.

What is the current status of trial NCT05766475?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2023-03-13. Estimated completion is 2027-06.

What conditions does trial NCT05766475 study?

This clinical trial studies the following conditions: Postpartum Depression.

What interventions are being tested in trial NCT05766475?

The interventions under investigation include: ROSE Program: In Person (BEHAVIORAL), ROSE Program: Virtual (BEHAVIORAL).

Who is sponsoring clinical trial NCT05766475?

This trial is sponsored by University of Denver, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766475 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.